• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH; MESH, SURGICAL Back to Search Results
Catalog Number E0.8P8
Device Problem Peeled/Delaminated (1454)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/06/2018
Event Type  malfunction  
Manufacturer Narrative
We have received the complaint patch for evaluation and we have confirmed the reported incident with this patch.The patch was observed to have delaminated about 3 cm at one end of the patch.At the same end, we also observed a suture that the surgeon had pierced through the patch.No other defects were noted in this patch.This patch was checked by the operating team before the procedure and was found to be acceptable.During manufacturing, each patch is inspected by our manufacturing as well as by the qc staff for such defect.It is highly unlikely for the inspection team would have missed such a visible defect.Our review of the lot history records for this lot did not find any discrepancies either in the manufacturing or packaging process that could be related to this incident.Further, we have not received any other complaints of a similar nature for devices from this lot.Therefore, we believe that it was an isolated incident.We have also performed a review of complaint history for such incidents for last 10 years for this device.The rate of occurrence for such incident is (b)(4) which is in line with our risk documents.Our ifu properly instructs users not to use cutting point armed sutures or traumatic instruments during the procedure as this may damage the patch.The patch was then removed and replaced with another patch.
 
Event Description
Patch started to delaminate while suturing into the carotid artery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XENOSURE BIOLOGICAL PATCH
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer Contact
pragya thikey
63 second ave
burlington, MA 01803
7812212266
MDR Report Key8139850
MDR Text Key130626573
Report Number1220948-2018-00104
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040835
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2024
Device Catalogue NumberE0.8P8
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/26/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/08/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/09/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-